{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:03Z","timestamp":1792547463410,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04795-5","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:39:48Z","timestamp":1778499588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Electronic nose versus gas chromatography \u2013 mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9787-4460","authenticated-orcid":false,"given":"Moustafa S.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-8533","authenticated-orcid":false,"given":"Mohamed S.","family":"Mshaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6834-019X","authenticated-orcid":false,"given":"Hend N.","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5294-4762","authenticated-orcid":false,"given":"Mamdouh M.","family":"Shawki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-7297","authenticated-orcid":false,"given":"Radwa A.","family":"Meshref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-1928","authenticated-orcid":false,"given":"Ehab I.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"2","key":"4795_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21709","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(2):93\u2013115. https:\/\/doi.org\/10.3322\/caac.21709.","journal-title":"CA Cancer J Clin"},{"key":"4795_CR2","doi-asserted-by":"publisher","unstructured":"Reig M, Sanduzzi-Zamparelli M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M. rt al. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update. J Hepatol. 2026;84(3):631\u2013654. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.020.","DOI":"10.1016\/j.jhep.2025.10.020"},{"key":"#cr-split#-4795_CR3.1","unstructured":"Tsoris A, Marlar CA. Last Accessed January 23,. Use of the Child Pugh Score in Liver Disease. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"key":"#cr-split#-4795_CR3.2","unstructured":"2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542308\/ (2026)."},{"issue":"7","key":"4795_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","volume":"97","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97(7):1005\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6603932.","journal-title":"Br J Cancer"},{"issue":"4","key":"4795_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jnci.2016.06.001","volume":"28","author":"DH Ziada","year":"2016","unstructured":"Ziada DH, El Sadany S, Soliman H, Abd-Elsalam S, Salama M, Hawash N, et al. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single-center study. J Egypt Natl Canc Inst. 2016;28(4):257\u201362. https:\/\/doi.org\/10.1016\/j.jnci.2016.06.001.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"3","key":"4795_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12029-013-9573-8","volume":"45","author":"AE Azm","year":"2014","unstructured":"Azm AE, Yousef AR, Mansour M, Awad N, El Dardiry A, Abdel Aziz S. New insights on non-B non-C hepatocellular carcinoma in Mid Delta region, Egypt. J Gastrointest Cancer. 2014;45(3):276\u201383. https:\/\/doi.org\/10.1007\/s12029-013-9573-8.","journal-title":"J Gastrointest Cancer"},{"issue":"4","key":"4795_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jebm.12270","volume":"10","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O, Helbling D, Sch\u00f6b O, Eltobgy M, Mohamed H, Schmidt J, et al. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies. J Evid Based Med. 2017;10(4):262\u201373. https:\/\/doi.org\/10.1111\/jebm.12270.","journal-title":"J Evid Based Med"},{"key":"4795_CR8","volume-title":"Egyptian National Guidelines for Hepatocellular Carcinoma","author":"Egyptian Health Council","year":"2025","unstructured":"Egyptian Health Council. Egyptian National Guidelines for Hepatocellular Carcinoma. Cairo: Egyptian Health Council; 2025."},{"issue":"6","key":"4795_CR9","first-page":"1384","volume":"7","author":"J Jin","year":"2017","unstructured":"Jin J, Zhang XY, Shi JL, Xue XF, Lu LL, Lu JH, et al. Application of AFP whole blood one-step rapid detection kit in screening for HCC in Qidong. Am J Cancer Res. 2017;7(6):1384\u20138.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"4795_CR10","doi-asserted-by":"publisher","first-page":"026010","DOI":"10.1088\/1752-7163\/ab7c1f","volume":"14","author":"G Ferrandino","year":"2020","unstructured":"Ferrandino G, Orf I, Smith R, Calcagno M, Thind AK, Debiram-Beecham I, et al. Breath biopsy assessment of liver disease using an exogenous volatile organic compound\u2014toward improved detection of liver impairment. J Breath Res. 2020;14(2):026010. https:\/\/doi.org\/10.1088\/1752-7163\/ab7c1f.","journal-title":"J Breath Res"},{"issue":"1","key":"4795_CR11","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1038\/s41598-022-08678-z","volume":"12","author":"T Sukaram","year":"2022","unstructured":"Sukaram T, Tansawat R, Apiparakoon T, Tiyarattanachai T, Marukatat S, Rerknimitr R, et al. Exhaled volatile organic compounds for diagnosis of hepatocellular carcinoma. Sci Rep. 2022;12(1):5326. https:\/\/doi.org\/10.1038\/s41598-022-08678-z.","journal-title":"Sci Rep"},{"key":"4795_CR12","doi-asserted-by":"publisher","first-page":"340752","DOI":"10.1016\/j.aca.2023.340752","volume":"1242","author":"NU Nazir","year":"2023","unstructured":"Nazir NU, Abbas SR. Identification of phenol 2,2-methylene bis,6[1,1-D] as breath biomarker of hepatocellular carcinoma patients and its electrochemical sensing: E-nose biosensor for HCC. Anal Chim Acta. 2023;1242:340752. https:\/\/doi.org\/10.1016\/j.aca.2023.340752.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"4795_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/biomedicines13010109","volume":"13","author":"T Hara","year":"2025","unstructured":"Hara T, Meng S, Arao Y, Saito Y, Inoue K, Alshammari AH, et al. Non-Invasive detection of tumors by volatile organic compounds in urine. Biomedicines. 2025;13(1):109. https:\/\/doi.org\/10.3390\/biomedicines13010109.","journal-title":"Biomedicines"},{"key":"4795_CR14","doi-asserted-by":"publisher","first-page":"117831","DOI":"10.1016\/j.cca.2024.117831","volume":"556","author":"T Sukaram","year":"2024","unstructured":"Sukaram T, Tansawat R, Phathong C, Rerknimitr R, Chaiteerakij R. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients. Clin Chim Acta. 2024;556:117831. https:\/\/doi.org\/10.1016\/j.cca.2024.117831.","journal-title":"Clin Chim Acta"},{"key":"4795_CR15","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.3390\/s19173656","volume":"19","author":"D Germanese","year":"2019","unstructured":"Germanese D, Colantonio S, D\u2019Acunto M, Romagnoli V, Salvati A, Brunetto M. An e-nose for the monitoring of severe liver impairment: a preliminary study. Sensors. 2019;19:3656. https:\/\/doi.org\/10.3390\/s19173656.","journal-title":"Sensors"},{"key":"4795_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/hon.2130","volume":"32","author":"EI Mohamed","year":"2014","unstructured":"Mohamed EI, Mahmoud GN, El-Sharkawy RM, Moro AM, Abdel-Mageed SM, Kotb MA. Electronic nose for tracking different types of leukaemia: future prospects in diagnosis. Hematol Oncol. 2014;32:165\u20137. https:\/\/doi.org\/10.1002\/hon.2130.","journal-title":"Hematol Oncol"},{"key":"4795_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7243\/2057-1631-4-3","volume":"4","author":"EI Mohamed","year":"2017","unstructured":"Mohamed EI, Moustafa MH, Mohamed MA, Awad SI, Maghraby HK, Godeto TW, et al. Qualitative and quantitative analysis of biological samples from non-metastatic breast cancer patients. Breast Cancer Rep. 2017;4:3.","journal-title":"Breast Cancer Rep"},{"key":"4795_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.5588\/ijtld.16.0823","volume":"21","author":"EI Mohamed","year":"2017","unstructured":"Mohamed EI, Mohamed MA, Moustafa MH, Abdel-Mageed SM, Moro AM, Baess AI, et al. Qualitative analysis of biological tuberculosis samples by an electronic nose-based artificial neural network. Int J Tuberc Lung Dis. 2017;21:810\u20137. https:\/\/doi.org\/10.5588\/ijtld.16.0823.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4795_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.32725\/jab.2019.006","volume":"17","author":"EI Mohamed","year":"2019","unstructured":"Mohamed EI, Mohamed MA, Abdel-Mageed SM, Abdel-Mohdy TS, Badawi MI, Darwish SH. Volatile organic compounds of biofluids for detecting lung cancer by an electronic nose based on artificial neural network. J Appl Biomed. 2019;17:67\u201374. https:\/\/doi.org\/10.32725\/jab.2019.006.","journal-title":"J Appl Biomed"},{"key":"4795_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jvh.13620","volume":"29","author":"EI Mohamed","year":"2022","unstructured":"Mohamed EI, El-Ghnam SM, Bayoumi AM, Abdel-Mageed SM, Ghareeb DA, Ross B. Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients. J Viral Hepat. 2022;29:147\u201355. https:\/\/doi.org\/10.1111\/jvh.13620.","journal-title":"J Viral Hepat"},{"key":"4795_CR21","doi-asserted-by":"publisher","first-page":"27529","DOI":"10.1038\/s41598-025-27529-1","volume":"15","author":"NE Ahmed","year":"2025","unstructured":"Ahmed NE, Mshaly MS, Madbouly KM, Mohamed MA, Abdel-Wahab EA, Mohamed EI. Analysis of volatile organic compounds in biological samples of colorectal cancer patients using electronic nose-based machine learning techniques. Sci Rep. 2025;15:27529. https:\/\/doi.org\/10.1038\/s41598-025-27529-1.","journal-title":"Sci Rep"},{"key":"4795_CR22","doi-asserted-by":"publisher","first-page":"978110","DOI":"10.3389\/fnut.2022.978110","volume":"9","author":"C Jiang","year":"2022","unstructured":"Jiang C, Wang Y, Fu W, Zhang G, Feng X, Wang X, et al. Association between sarcopenia and prognosis of hepatocellular carcinoma: a systematic review and meta-analysis. Front Nutr. 2022;9:978110. https:\/\/doi.org\/10.3389\/fnut.2022.978110.","journal-title":"Front Nutr"},{"key":"4795_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11901-025-00686-7","volume":"24","author":"JS Norman","year":"2025","unstructured":"Norman JS, Mehta N. The Role of AFP-L3 and DCP Biomarkers in the Diagnosis and Management of Hepatocellular Carcinoma. Curr Hepatol Rep. 2025;24:16. https:\/\/doi.org\/10.1007\/s11901-025-00686-7.","journal-title":"Curr Hepatol Rep"},{"key":"4795_CR24","doi-asserted-by":"publisher","unstructured":"Shen X, Xie C, Zhang S, Ai W, Yu Z, Ye X. The detection of serum-volatile organic compounds in the diagnostics of hepatocellular carcinoma using gas chromatography\u2013ion mobility spectrometry. Front Chem 25;13:1672220. https:\/\/doi.org\/10.3389\/fchem.2025.1672220.","DOI":"10.3389\/fchem.2025.1672220"},{"key":"4795_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.15.22275001","author":"Volatile organic compounds","year":"2022","unstructured":"Volatile organic compounds. and cytochrome P450 dysfunction in hepatocellular carcinoma. medRxiv [Preprint]. 2022. https:\/\/doi.org\/10.1101\/2022.05.15.22275001.","journal-title":"medRxiv [Preprint]"},{"issue":"9","key":"4795_CR26","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/molecules26092447","volume":"26","author":"AS Bannaga","year":"2021","unstructured":"Bannaga AS, Tyagi H, Daulton E, Covington JA, Arasaradnam RP. Exploratory study using urinary volatile organic compounds for the detection of hepatocellular carcinoma. Molecules. 2021;26(9):2447. https:\/\/doi.org\/10.3390\/molecules26092447.","journal-title":"Molecules"},{"key":"4795_CR27","doi-asserted-by":"publisher","first-page":"1448760","DOI":"10.3389\/fonc.2024.1448760","volume":"14","author":"A Goertzen","year":"2024","unstructured":"Goertzen A, Kidane B, Ahmed N, Aliani M. Potential urinary volatile organic compounds as screening markers in cancer \u2013 a review. Front Oncol. 2024;14:1448760. https:\/\/doi.org\/10.3389\/fonc.2024.1448760.","journal-title":"Front Oncol"},{"issue":"1","key":"4795_CR28","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.iliver.2023.09.001","volume":"3","author":"S Metwaly","year":"2024","unstructured":"Metwaly S, Psica A, Sogaolu O, Ahmed I, Mukhopadhya A, Delibegovi\u0107 M, et al. Volatile organic compounds for the detection of hepatocellular carcinoma\u2014A scoping review. iLiver. 2024;3(1):100070. https:\/\/doi.org\/10.1016\/j.iliver.2023.09.001.","journal-title":"iLiver"},{"key":"4795_CR29","doi-asserted-by":"publisher","unstructured":"Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Molec Med. 2026,57(3):58. https:\/\/doi.org\/10.3892\/ijmm. 2026.5729.","DOI":"10.3892\/ijmm"},{"key":"4795_CR30","doi-asserted-by":"publisher","first-page":"1714314","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li J, Liang YB, Chen XM, Ou ZY, Wang QB, Luo WL, et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front Immunol. 2026;17:1714314. https:\/\/doi.org\/10.3389\/fimmu.2026.1714314.","journal-title":"Front Immunol"},{"key":"4795_CR31","doi-asserted-by":"publisher","DOI":"10.1159\/000549355","author":"J Li","year":"2025","unstructured":"Li J, Liang YB, Wang QB, Luo WL, Chen XM, Lakang Y, et al. Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: A narrative review. Liver Cancer. 2025. https:\/\/doi.org\/10.1159\/000549355.","journal-title":"Liver Cancer"},{"key":"4795_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12951-025-02368-9","volume":"23","author":"Z Jia","year":"2025","unstructured":"Jia Z, Jiang Y, Shang T, Cao H, Li J, Cong L, et al. Advanced strategy for cancer detection based on volatile organic compounds in breath. J Nanobiotechnol. 2025;23:468. https:\/\/doi.org\/10.1186\/s12951-025-02368-9.","journal-title":"J Nanobiotechnol"},{"key":"4795_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.20517\/2394-4722.2024.85","volume":"11","author":"AJ Moshayedi","year":"2025","unstructured":"Moshayedi AJ, Khan AS, Chen M, Piccaluga PP. ENose: a new frontier for non-invasive cancer detection and monitoring. J Cancer Metastasis Treat. 2025;11:6. https:\/\/doi.org\/10.20517\/2394-4722.2024.85.","journal-title":"J Cancer Metastasis Treat"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04795-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:39:51Z","timestamp":1778499591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04795-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4795"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04795-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Medical Research Institute at Alexandria University in Alexandria, Egypt, approved the study protocol with Approval No. E\/C.S\/N.T143\/2022. All patients had given their informed written consent stating the title, procedure, and purpose of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}